Bloomberg Law
Free Newsletter Sign Up
Login
BROWSE
Bloomberg Law
Welcome
Login
Advanced Search Go
Free Newsletter Sign Up

Fewer New Policies Expected From FDA With Acting Chief in Place

June 4, 2019, 7:52 PM

Fewer announcements and initiatives will come out of the FDA until the White House installs a permanent head to the agency, the agency’s longtime drug chief said June 4.

“It’s very difficult for an acting commissioner to make new policy directions and so forth,” said Janet Woodock, who heads the Food and Drug Administration’s drug center and has been with the agency since 1986. said. “Fortunately Scott [Gottlieb] left us with plenty to do.”

Scott Gottlieb stepped down as FDA commissioner in early April after about two years in office. Ned Sharpless, who came over from the National Cancer Institute ...